Wednesday, 1 June 2022

Florida abortion providers file lawsuit challenging 15-week ban

Florida abortion providers file lawsuit challenging 15-week ban

A group of Florida abortion providers including affiliates of Planned Parenthood filed a lawsuit on Wednesday challenging the state's new Republican-backed ban on abortions after 15 weeks of pregnancy, saying the measure violates the state's constitution.

Walmart shareholder proposal on abortion ban impact fails

A proposal made by an activist shareholder and opposed by Walmart Inc management asking the retailer to produce a report assessing the impact on its employees if the U.S. Supreme Court rolls back abortion rights was voted down on Wednesday at its annual general meeting.

U.S. to import Bubs Australia baby formula next week -White House

The United States will ship in baby formula made by Bubs Australia Ltd next week, the White House said on Wednesday, adding the shipment being sent to Pennsylvania and California would be enough to fill 4.6 million 8-ounce baby bottles.

Canada authorizes Pfizer COVID-19 booster for 16 and 17-year-olds

Canada on Wednesday authorized a single booster shot of Pfizer and partner BioNTech's COVID-19 vaccine for 16- and 17-year-olds.

Health agency confirms community spread of monkeypox in England

Monkeypox appears to be spreading from person to person in England, the UK Health Security Agency (UKHSA) said on Wednesday.

Outbreaks of diseases such as monkeypox becoming more frequent, warns WHO

Outbreaks of endemic diseases such as monkeypox and lassa fever are becoming more persistent and frequent, the WHO emergencies director, Mike Ryan, warned on Wednesday.

COVID cases rise in the Americas, nations must also monitor other viruses -PAHO

COVID-19 cases in the Americas increased 10.4% last week from the previous one, but countries must also pay attention to a rise in other respiratory viruses in the region, the Pan American Health Organization (PAHO) said on Wednesday.

U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.

FDA withdraws approval for TG Therapeutics cancer treatment

The U.S. Food and Drug Administration said on Wednesday it has withdrawn its approval for TG Therapeutics Inc's lymphatic cancer treatment Ukoniq over concerns of higher risk of death in patients receiving the drug.

Italy's monkeypox cases rise to 20, will increase further - deputy minister

Cases of monkeypox in Italy have risen to 20 and are set to increase further in the coming days, the country's deputy health minister said on Wednesday.

Related Videos

Monkeypox "will not be like COVID" - Spanish microbiologist

Monkeypox can be contained if we act now: WHO

N.Korea reports more deaths amid COVID lockdown